Global Gastroesophageal Reflux Disease (GERD) Therapeutics Market Research Report 2022

Global Gastroesophageal Reflux Disease (GERD) Therapeutics Market Research Report 2022

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
1.2.2 Antacids
1.2.3 Pro-kinetic agents
1.2.4 H2 Receptor Blockers
1.2.5 Proton Pump Inhibitors (PPIs)
1.3 Market by Application
1.3.1 Global Gastroesophageal Reflux Disease (GERD) Therapeutics Market Share by Application: 2017 VS 2021 VS 2028
1.3.2 Heartburn
1.3.3 Acid reflux disorders
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Gastroesophageal Reflux Disease (GERD) Therapeutics Market Perspective (2017-2028)
2.2 Gastroesophageal Reflux Disease (GERD) Therapeutics Growth Trends by Region
2.2.1 Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Gastroesophageal Reflux Disease (GERD) Therapeutics Historic Market Size by Region (2017-2022)
2.2.3 Gastroesophageal Reflux Disease (GERD) Therapeutics Forecasted Market Size by Region (2023-2028)
2.3 Gastroesophageal Reflux Disease (GERD) Therapeutics Market Dynamics
2.3.1 Gastroesophageal Reflux Disease (GERD) Therapeutics Industry Trends
2.3.2 Gastroesophageal Reflux Disease (GERD) Therapeutics Market Drivers
2.3.3 Gastroesophageal Reflux Disease (GERD) Therapeutics Market Challenges
2.3.4 Gastroesophageal Reflux Disease (GERD) Therapeutics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Gastroesophageal Reflux Disease (GERD) Therapeutics Players by Revenue
3.1.1 Global Top Gastroesophageal Reflux Disease (GERD) Therapeutics Players by Revenue (2017-2022)
3.1.2 Global Gastroesophageal Reflux Disease (GERD) Therapeutics Revenue Market Share by Players (2017-2022)
3.2 Global Gastroesophageal Reflux Disease (GERD) Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Gastroesophageal Reflux Disease (GERD) Therapeutics Revenue
3.4 Global Gastroesophageal Reflux Disease (GERD) Therapeutics Market Concentration Ratio
3.4.1 Global Gastroesophageal Reflux Disease (GERD) Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Gastroesophageal Reflux Disease (GERD) Therapeutics Revenue in 2021
3.5 Gastroesophageal Reflux Disease (GERD) Therapeutics Key Players Head office and Area Served
3.6 Key Players Gastroesophageal Reflux Disease (GERD) Therapeutics Product Solution and Service
3.7 Date of Enter into Gastroesophageal Reflux Disease (GERD) Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Gastroesophageal Reflux Disease (GERD) Therapeutics Breakdown Data by Type
4.1 Global Gastroesophageal Reflux Disease (GERD) Therapeutics Historic Market Size by Type (2017-2022)
4.2 Global Gastroesophageal Reflux Disease (GERD) Therapeutics Forecasted Market Size by Type (2023-2028)
5 Gastroesophageal Reflux Disease (GERD) Therapeutics Breakdown Data by Application
5.1 Global Gastroesophageal Reflux Disease (GERD) Therapeutics Historic Market Size by Application (2017-2022)
5.2 Global Gastroesophageal Reflux Disease (GERD) Therapeutics Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size (2017-2028)
6.2 North America Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Country (2017-2022)
6.3 North America Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Country (2023-2028)
6.4 United States
6.5 Canada
7 Europe
7.1 Europe Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size (2017-2028)
7.2 Europe Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Country (2017-2022)
7.3 Europe Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Country (2023-2028)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size (2017-2028)
8.2 Asia-Pacific Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Country (2017-2022)
8.3 Asia-Pacific Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Country (2023-2028)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
9 Latin America
9.1 Latin America Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size (2017-2028)
9.2 Latin America Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Country (2017-2022)
9.3 Latin America Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Country (2023-2028)
9.4 Mexico
9.5 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size (2017-2028)
10.2 Middle East & Africa Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Country (2017-2022)
10.3 Middle East & Africa Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Country (2023-2028)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
11 Key Players Profiles
11.1 AstraZeneca
11.1.1 AstraZeneca Company Detail
11.1.2 AstraZeneca Business Overview
11.1.3 AstraZeneca Gastroesophageal Reflux Disease (GERD) Therapeutics Introduction
11.1.4 AstraZeneca Revenue in Gastroesophageal Reflux Disease (GERD) Therapeutics Business (2017-2022)
11.1.5 AstraZeneca Recent Development
11.2 Eisai
11.2.1 Eisai Company Detail
11.2.2 Eisai Business Overview
11.2.3 Eisai Gastroesophageal Reflux Disease (GERD) Therapeutics Introduction
11.2.4 Eisai Revenue in Gastroesophageal Reflux Disease (GERD) Therapeutics Business (2017-2022)
11.2.5 Eisai Recent Development
11.3 GSK
11.3.1 GSK Company Detail
11.3.2 GSK Business Overview
11.3.3 GSK Gastroesophageal Reflux Disease (GERD) Therapeutics Introduction
11.3.4 GSK Revenue in Gastroesophageal Reflux Disease (GERD) Therapeutics Business (2017-2022)
11.3.5 GSK Recent Development
11.4 Takeda
11.4.1 Takeda Company Detail
11.4.2 Takeda Business Overview
11.4.3 Takeda Gastroesophageal Reflux Disease (GERD) Therapeutics Introduction
11.4.4 Takeda Revenue in Gastroesophageal Reflux Disease (GERD) Therapeutics Business (2017-2022)
11.4.5 Takeda Recent Development
11.5 Johnson & Johnson
11.5.1 Johnson & Johnson Company Detail
11.5.2 Johnson & Johnson Business Overview
11.5.3 Johnson & Johnson Gastroesophageal Reflux Disease (GERD) Therapeutics Introduction
11.5.4 Johnson & Johnson Revenue in Gastroesophageal Reflux Disease (GERD) Therapeutics Business (2017-2022)
11.5.5 Johnson & Johnson Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
Table 2. Key Players of Antacids
Table 3. Key Players of Pro-kinetic agents
Table 4. Key Players of H2 Receptor Blockers
Table 5. Key Players of Proton Pump Inhibitors (PPIs)
Table 6. Global Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
Table 7. Global Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 8. Global Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Region (2017-2022) & (US$ Million)
Table 9. Global Gastroesophageal Reflux Disease (GERD) Therapeutics Market Share by Region (2017-2022)
Table 10. Global Gastroesophageal Reflux Disease (GERD) Therapeutics Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 11. Global Gastroesophageal Reflux Disease (GERD) Therapeutics Market Share by Region (2023-2028)
Table 12. Gastroesophageal Reflux Disease (GERD) Therapeutics Market Trends
Table 13. Gastroesophageal Reflux Disease (GERD) Therapeutics Market Drivers
Table 14. Gastroesophageal Reflux Disease (GERD) Therapeutics Market Challenges
Table 15. Gastroesophageal Reflux Disease (GERD) Therapeutics Market Restraints
Table 16. Global Gastroesophageal Reflux Disease (GERD) Therapeutics Revenue by Players (2017-2022) & (US$ Million)
Table 17. Global Gastroesophageal Reflux Disease (GERD) Therapeutics Market Share by Players (2017-2022)
Table 18. Global Top Gastroesophageal Reflux Disease (GERD) Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gastroesophageal Reflux Disease (GERD) Therapeutics as of 2021)
Table 19. Ranking of Global Top Gastroesophageal Reflux Disease (GERD) Therapeutics Companies by Revenue (US$ Million) in 2021
Table 20. Global 5 Largest Players Market Share by Gastroesophageal Reflux Disease (GERD) Therapeutics Revenue (CR5 and HHI) & (2017-2022)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Gastroesophageal Reflux Disease (GERD) Therapeutics Product Solution and Service
Table 23. Date of Enter into Gastroesophageal Reflux Disease (GERD) Therapeutics Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Type (2017-2022) & (US$ Million)
Table 26. Global Gastroesophageal Reflux Disease (GERD) Therapeutics Revenue Market Share by Type (2017-2022)
Table 27. Global Gastroesophageal Reflux Disease (GERD) Therapeutics Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 28. Global Gastroesophageal Reflux Disease (GERD) Therapeutics Revenue Market Share by Type (2023-2028)
Table 29. Global Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Application (2017-2022) & (US$ Million)
Table 30. Global Gastroesophageal Reflux Disease (GERD) Therapeutics Revenue Market Share by Application (2017-2022)
Table 31. Global Gastroesophageal Reflux Disease (GERD) Therapeutics Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 32. Global Gastroesophageal Reflux Disease (GERD) Therapeutics Revenue Market Share by Application (2023-2028)
Table 33. North America Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Country (2017-2022) & (US$ Million)
Table 34. North America Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Country (2023-2028) & (US$ Million)
Table 35. Europe Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Country (2017-2022) & (US$ Million)
Table 36. Europe Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Country (2023-2028) & (US$ Million)
Table 37. Asia-Pacific Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Region (2017-2022) & (US$ Million)
Table 38. Asia-Pacific Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Region (2023-2028) & (US$ Million)
Table 39. Latin America Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Country (2017-2022) & (US$ Million)
Table 40. Latin America Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Country (2023-2028) & (US$ Million)
Table 41. Middle East & Africa Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Country (2017-2022) & (US$ Million)
Table 42. Middle East & Africa Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Country (2023-2028) & (US$ Million)
Table 43. AstraZeneca Company Detail
Table 44. AstraZeneca Business Overview
Table 45. AstraZeneca Gastroesophageal Reflux Disease (GERD) Therapeutics Product
Table 46. AstraZeneca Revenue in Gastroesophageal Reflux Disease (GERD) Therapeutics Business (2017-2022) & (US$ Million)
Table 47. AstraZeneca Recent Development
Table 48. Eisai Company Detail
Table 49. Eisai Business Overview
Table 50. Eisai Gastroesophageal Reflux Disease (GERD) Therapeutics Product
Table 51. Eisai Revenue in Gastroesophageal Reflux Disease (GERD) Therapeutics Business (2017-2022) & (US$ Million)
Table 52. Eisai Recent Development
Table 53. GSK Company Detail
Table 54. GSK Business Overview
Table 55. GSK Gastroesophageal Reflux Disease (GERD) Therapeutics Product
Table 56. GSK Revenue in Gastroesophageal Reflux Disease (GERD) Therapeutics Business (2017-2022) & (US$ Million)
Table 57. GSK Recent Development
Table 58. Takeda Company Detail
Table 59. Takeda Business Overview
Table 60. Takeda Gastroesophageal Reflux Disease (GERD) Therapeutics Product
Table 61. Takeda Revenue in Gastroesophageal Reflux Disease (GERD) Therapeutics Business (2017-2022) & (US$ Million)
Table 62. Takeda Recent Development
Table 63. Johnson & Johnson Company Detail
Table 64. Johnson & Johnson Business Overview
Table 65. Johnson & Johnson Gastroesophageal Reflux Disease (GERD) Therapeutics Product
Table 66. Johnson & Johnson Revenue in Gastroesophageal Reflux Disease (GERD) Therapeutics Business (2017-2022) & (US$ Million)
Table 67. Johnson & Johnson Recent Development
Table 68. Research Programs/Design for This Report
Table 69. Key Data Information from Secondary Sources
Table 70. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Gastroesophageal Reflux Disease (GERD) Therapeutics Market Share by Type: 2021 VS 2028
Figure 2. Antacids Features
Figure 3. Pro-kinetic agents Features
Figure 4. H2 Receptor Blockers Features
Figure 5. Proton Pump Inhibitors (PPIs) Features
Figure 6. Global Gastroesophageal Reflux Disease (GERD) Therapeutics Market Share by Application in 2021 & 2028
Figure 7. Heartburn Case Studies
Figure 8. Acid reflux disorders Case Studies
Figure 9. Gastroesophageal Reflux Disease (GERD) Therapeutics Report Years Considered
Figure 10. Global Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 11. Global Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 12. Global Gastroesophageal Reflux Disease (GERD) Therapeutics Market Share by Region: 2021 VS 2028
Figure 13. Global Gastroesophageal Reflux Disease (GERD) Therapeutics Market Share by Players in 2021
Figure 14. Global Top Gastroesophageal Reflux Disease (GERD) Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gastroesophageal Reflux Disease (GERD) Therapeutics as of 2021)
Figure 15. The Top 10 and 5 Players Market Share by Gastroesophageal Reflux Disease (GERD) Therapeutics Revenue in 2021
Figure 16. North America Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 17. North America Gastroesophageal Reflux Disease (GERD) Therapeutics Market Share by Country (2017-2028)
Figure 18. United States Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 19. Canada Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 20. Europe Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 21. Europe Gastroesophageal Reflux Disease (GERD) Therapeutics Market Share by Country (2017-2028)
Figure 22. Germany Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 23. France Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 24. U.K. Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 25. Italy Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 26. Russia Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 27. Nordic Countries Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. Asia-Pacific Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. Asia-Pacific Gastroesophageal Reflux Disease (GERD) Therapeutics Market Share by Region (2017-2028)
Figure 30. China Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. Japan Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. South Korea Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. Southeast Asia Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 34. India Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 35. Australia Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 36. Latin America Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 37. Latin America Gastroesophageal Reflux Disease (GERD) Therapeutics Market Share by Country (2017-2028)
Figure 38. Mexico Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. Brazil Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. Middle East & Africa Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. Middle East & Africa Gastroesophageal Reflux Disease (GERD) Therapeutics Market Share by Country (2017-2028)
Figure 42. Turkey Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 43. Saudi Arabia Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 44. AstraZeneca Revenue Growth Rate in Gastroesophageal Reflux Disease (GERD) Therapeutics Business (2017-2022)
Figure 45. Eisai Revenue Growth Rate in Gastroesophageal Reflux Disease (GERD) Therapeutics Business (2017-2022)
Figure 46. GSK Revenue Growth Rate in Gastroesophageal Reflux Disease (GERD) Therapeutics Business (2017-2022)
Figure 47. Takeda Revenue Growth Rate in Gastroesophageal Reflux Disease (GERD) Therapeutics Business (2017-2022)
Figure 48. Johnson & Johnson Revenue Growth Rate in Gastroesophageal Reflux Disease (GERD) Therapeutics Business (2017-2022)
Figure 49. Bottom-up and Top-down Approaches for This Report
Figure 50. Data Triangulation
Figure 51. Key Executives Interviewed

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Nuclear Medicine Cyclotron Systems Market Report, History and Forecast 2018-2029

Published: 11-Jan-2024        Price: US 3350 Onwards        Pages: 118

The global Nuclear Medicine Cyclotron Systems market was valued at US$ 220.85 million in 2022 and will reach US$ 283.75 million by the end of 2029, growing at a CAGR of 4.38% during 2023-2029. Asia-Pacific market for Nuclear Medicine Cyclotron Systems was valued at $ 61.16 million in 2022 and will reach $ 104.22 million by 2029, at a CAGR of 5.84% during the forecast period of 2023 through 2029. Report Scope This report aims to provide a comprehensive presentation of the glo......

Global Non-imaging Diagnostic Catheter Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 95

The global Non-imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Imaging Diagnostic Catheter Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 90

The global Imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated......

Global PCR Equipment Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 77

The global PCR Equipment market was valued at US$ 806 million in 2023 and is anticipated to reach US$ 1230.7 million by 2030, witnessing a CAGR of 6.7% during The forecast period 2024-2030. PCR (Polymerase Chain Reaction) equipment is widely used in molecular biology and genetics research for amplifying DNA and RNA sequences. The market for PCR equipment is influenced by several key drivers. Here are some of The significant market drivers: Advancements in Research and Diagnost......

Global Disposable Sterile Syringes and Needles Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 109

The global Disposable Sterile Syringes and Needles market was valued at US$ 404.4 million in 2023 and is anticipated to reach US$ 539.1 million by 2030, witnessing a CAGR of 2.1% during The forecast period 2024-2030. North American market for Disposable Sterile Syringes and Needles is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Disposable Sterile Syringes and N......

Global Orthopaedic Power Tools Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Orthopaedic Power Tools market was valued at US$ 463.3 million in 2023 and is anticipated to reach US$ 746.5 million by 2030, witnessing a CAGR of 7.3% during The forecast period 2024-2030. North American market for Orthopaedic Power Tools is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Orthopaedic Power Tools is estimated to increase from $ million i......

Global Cerebrospinal Fluid Management Devices Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Cerebrospinal Fluid Management Devices market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Cerebrospinal Fluid Management Devices is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Cerebrospinal Fluid Management Devices is estimate......

Global CAD & CAM Milling Burs Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 79

The global CAD & CAM Milling Burs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ ......

Global Artificial Teeth Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 98

The global Artificial Teeth market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, a......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs